| Title |
Pharmaceutical care program for type 2 diabetes patients in Brazil: a randomised controlled trial
|
|---|---|
| Published in |
International Journal of Clinical Pharmacy, November 2012
|
| DOI | 10.1007/s11096-012-9710-7 |
| Pubmed ID | |
| Authors |
Aline Oliveira Magalhães Mourão, Wandiclécia Rodrigues Ferreira, Maria Auxiliadora Parreiras Martins, Adriano Max Moreira Reis, Maria Ruth Gaede Carrillo, Andrea Grabe Guimarães, Lisiane Silveira Ev |
| Abstract |
Brazilians with type 2 diabetes require action to improve haemoglobin A1C levels considering the fact that approximately 73 % of them have poor glycaemic control. Evidence has shown the potential benefits of pharmaceutical care programs in type 2 diabetes patients. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 159 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 9 | 6% |
| United Kingdom | 1 | <1% |
| Ukraine | 1 | <1% |
| Denmark | 1 | <1% |
| Unknown | 147 | 92% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 22 | 14% |
| Student > Master | 22 | 14% |
| Student > Bachelor | 21 | 13% |
| Researcher | 17 | 11% |
| Student > Doctoral Student | 12 | 8% |
| Other | 30 | 19% |
| Unknown | 35 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 46 | 29% |
| Medicine and Dentistry | 35 | 22% |
| Nursing and Health Professions | 11 | 7% |
| Social Sciences | 7 | 4% |
| Agricultural and Biological Sciences | 5 | 3% |
| Other | 16 | 10% |
| Unknown | 39 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 November 2012.
All research outputs
#18,321,703
of 22,687,320 outputs
Outputs from International Journal of Clinical Pharmacy
#868
of 1,072 outputs
Outputs of similar age
#214,215
of 276,060 outputs
Outputs of similar age from International Journal of Clinical Pharmacy
#13
of 17 outputs
Altmetric has tracked 22,687,320 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,072 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one is in the 6th percentile – i.e., 6% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 276,060 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.